Efficacy of Invariant Natural Killer T Cell Infusion Plus Transarterial Embolization vs Transarterial Embolization Alone for Hepatocellular Carcinoma Patients: A Phase 2 Randomized Clinical Trial

PURPOSE: Invariant NKT cells (iNKT) are CD1d-restricted T cells with the capacity of antitumor immunity. The safety of autologous iNKT cell treatment in hepatocellular carcinoma (HCC) has been verified. This study aimed to investigate its efficacy in advanced HCC after transarterial chemoembolizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jia, Bao, Xuli, Liu, Fuquan, Guo, Jiang, Wu, Yifan, Xiong, Fang, Lu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455792/
https://www.ncbi.nlm.nih.gov/pubmed/37637501
http://dx.doi.org/10.2147/JHC.S416933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455792/
https://www.ncbi.nlm.nih.gov/pubmed/37637501
http://dx.doi.org/10.2147/JHC.S416933

Ejemplares similares